The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-insti…

Overview of attention for article published in this source, May 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 43 followers.

http://t.co/AVYuChLSAe

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.